| Options | Application |
| Research Grade |
* Molecular cloning * Mutagenesis * Southern blotting * Library construction |
| Transfection Grade |
* Transfection and co-transfection * Virus packaging * Protein manufacturing * Antibody production * Gene, vaccine, and gene therapy studies * Animal studies |
| Preclinical Grade |
* Virus production * DNA vaccines * Preclinical animal studies |

| QC Items | Specification |
| Appearance | Clear, no visible particles |
| A260/280 | 1.8≤OD260/OD280≤2.0 |
| Plasmid concentration | provide dry powder |
| Residual RNA | Non-detectable by gel electrophoresis |
| Genomic DNA | Non-detectable by gel electrophoresis |
| Endotoxin Assay |
Transfection grade <0.1 EU/μg; Preclinical grade<0.01 EU/μg |
| Bioburden Testing(optional add-on) | No growth on agar plate after 48 hours |
| Restriction analysis(optional add-on) | Conforming to reference pattern |
| Homogeneity(optional add-on) | Preclinical grade:≥ 90% supercoiled |
Sweep WeChat yards pay attention to us
24-hour hotline15972218552
The mobile phone15972218552
Copyright © 2022-2030 Wuhan Xingxing Biotechnology Co., Ltd. All rights reserved Address:Room 003, 4th Floor, Building D2, Software New City Phase III, No. 8 Huacheng Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province ICP:鄂ICP备2025107759号-1">鄂ICP备2025107759号-1